$13.170
+0.101 (+0.77%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CBIO por análisis de gráficos similares
Alphio's CBIO stock price prediction model matches the current Crescent Biopharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.08 (-0.69%). The 1-week path is $12.68 (-3.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Crescent Biopharma, Inc.?
Crescent Biopharma Inc is a good buy right now due to its promising developments in cancer treatment and a significant analyst upgrade. The current price is $11.84, which is well below the analyst price target of $36, indicating substantial upside potential. Additionally, the RSI is at 20.213, suggesting that the stock is oversold and may rebound. However, a risk to consider is the company's high net loss of $24.8 million reported in Q2 2026, which could affect its financial stability if not managed properly.
CBIO cerró en $13.17 el Wednesday, tras subir +0.77%
Crescent Biopharma, Inc. (CBIO) last closed at $13.17, gaining +0.77%. These facts feed the 1-day and 1-week CBIO price prediction above.
Factores de la previsión
Los factores de la previsión de Crescent Biopharma, Inc. (CBIO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CBIO, ordenadas por similitud.
Análisis de estacionalidad de CBIO
Historically the probability of a positive October return for CBIO is 24.59%. February offers the highest probability of a positive month at 79.31%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CBIO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $11.47 | $13.05 | $13.33 | -0.89% |
| Nov 2026 | $9.74 | $11.91 | $13.71 | -9.60% |
| Dec 2026 | $12.31 | $13.20 | $15.22 | +0.20% |
En 2026, se proyecta que Crescent Biopharma, Inc. (CBIO) oscile entre $9.74 y $15.22.
Previsión mensual de Crescent Biopharma, Inc. para 2026
En Oct de 2026, se proyecta que Crescent Biopharma, Inc. promedie $13.05, con un mínimo de $11.47 y un máximo de $13.33.
En Nov de 2026, se proyecta que Crescent Biopharma, Inc. promedie $11.91, con un mínimo de $9.74 y un máximo de $13.71.
En Dec de 2026, se proyecta que Crescent Biopharma, Inc. promedie $13.20, con un mínimo de $12.31 y un máximo de $15.22.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.